Skip to main content
Topchoice Medical Co.,Inc. logo

Topchoice Medical Co.,Inc. — Investor Relations & Filings

Ticker · 600763 ISIN · CNE000000MZ8 Shanghai Stock Exchange Human health and social work activities
Open in API
Filings indexed 1,950 across all filing types
Latest filing 2026-05-27 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 600763

About Topchoice Medical Co.,Inc.

http://www.tcmedical.com.cn/

Topchoice Medical Co., Inc. is a healthcare service provider specializing in the investment, management, and operation of medical institutions. The company primarily focuses on stomatology, maintaining an extensive network of dental hospitals and clinics. Its core clinical services encompass orthodontics, dental implantation, pediatric dentistry, and general oral surgery. The organization utilizes a hub-and-spoke operational model, centering on large-scale regional dental hospitals supported by multiple satellite clinics to provide comprehensive oral healthcare. In addition to its dental portfolio, the company has expanded its medical services to include assisted reproductive technology and ophthalmology. By integrating clinical practice with medical research and education, the company aims to standardize dental care delivery and enhance patient outcomes through advanced diagnostic and treatment technologies.

Recent filings

Filing Released Lang Actions
通策医疗股份有限公司关于控股股东部分股票解除质押的公告
Regulatory Filings Classification · 14% confidence The document is an official announcement by a listed company regarding the partial release (解质押) of shares pledged by its controlling shareholder. It does not present financial statements or constitute a report like an annual/interim report, nor is it an AGM or voting document. It is not a share issuance, buyback, or director insider trade in the sense defined, and thus falls into the general regulatory announcement/filing category.
2026-05-27 Chinese
通策医疗股份有限公司关于2025年年度暨2026年第一季度业绩暨现金分红说明会召开情况的公告
Management Reports Classification · 88% confidence The document is a summary of the company’s 2025 full‐year and 2026 Q1 performance, dividend distribution plan, strategic initiatives and Q&A with investors. It goes beyond a mere earnings release by providing management’s detailed explanation of results, business trends, outlook and strategic rationale. It is not a standalone interim report (no full financial statements), nor a simple press release or dividend notice. This aligns with a Management Discussion & Analysis (MDA) type document.
2026-05-11 Chinese
通策医疗股份有限公司关于召开2025年年度暨2026年第一季度业绩暨现金分红说明会的公告
Investor Presentation Classification · 95% confidence The document is an announcement about an upcoming investor meeting scheduled for May 11, 2026, to discuss the company's 2025 annual results and 2026 first quarter performance. It mentions that the company has already published the 2025 annual report and 2026 Q1 report on April 18, 2026, and this meeting is intended to provide further explanation and answer investor questions. The document does not contain actual financial statements or detailed financial data but rather details about the meeting logistics, participants, and how investors can participate. Therefore, this is an Investor Presentation (IP) type document, as it is a detailed presentation event for investors focusing on financials and company performance, not the report itself or a simple announcement of report publication.
2026-04-28 Chinese
通策医疗股份有限公司2025年年度报告
Annual Report Classification · 100% confidence The document is titled "通策医疗股份有限公司2025 年年度报告" which translates to "Topchoice Medical Co., Inc. 2025 Annual Report." It contains detailed financial data, management discussion and analysis, company overview, financial indicators, and audit information. The document length is 15,000 characters, indicating a comprehensive report rather than a brief announcement. It includes audited financial statements, management's discussion, and detailed operational and financial data for the fiscal year 2025. The presence of an audit report with an unqualified opinion is mentioned, but the document itself is not just the audit report. The content matches the definition of an Annual Report (10-K) as it covers the full fiscal year, detailed financial performance, and company activities. Therefore, the correct classification is Annual Report (10-K).
2026-04-17 Chinese
通策医疗股份有限公司对会计师事务所2025年度履职情况评估报告
Audit Report / Information Classification · 95% confidence The document is a detailed evaluation and report on the appointment and performance of an accounting firm (中汇会计师事务所) as the auditor for the company's 2025 fiscal year audit. It includes information about the auditor's qualifications, audit plan, quality control, and audit execution. The document mentions the issuance of an unqualified audit report and internal control audit report for the 2025 financial statements. The content focuses on the audit report and auditor's performance rather than the full annual report or financial statements themselves. The document length is 3206 characters, which is relatively short but contains substantive audit-related information, not just an announcement or certification. Therefore, it fits best as an Audit Report / Information (AR) rather than an Annual Report (10-K) or Regulatory Filing (RNS).
2026-04-17 Chinese
通策医疗股份有限公司2025年社会责任报告
Regulatory Filings
2026-04-17 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.